First Time Loading...
S

SciClone Pharmaceuticals (Holdings) Ltd
HKEX:6600

Watchlist Manager
SciClone Pharmaceuticals (Holdings) Ltd
HKEX:6600
Watchlist
Price: 18.08 HKD -0.22% Market Closed
Updated: May 6, 2024

SciClone Pharmaceuticals (Holdings) Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

SciClone Pharmaceuticals (Holdings) Ltd
Revenue Peer Comparison

Comparables:
H
3692
600436
600276
000538
C
300765

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
S
SciClone Pharmaceuticals (Holdings) Ltd
HKEX:6600
Revenue
¥3.2B
CAGR 3-Years
18%
CAGR 5-Years
18%
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Revenue
¥10.1B
CAGR 3-Years
5%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Revenue
¥9.7B
CAGR 3-Years
14%
CAGR 5-Years
16%
CAGR 10-Years
22%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Revenue
¥22.3B
CAGR 3-Years
-5%
CAGR 5-Years
7%
CAGR 10-Years
14%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Revenue
¥39.1B
CAGR 3-Years
6%
CAGR 5-Years
8%
CAGR 10-Years
9%
C
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
Revenue
¥2.5B
CAGR 3-Years
24%
CAGR 5-Years
15%
CAGR 10-Years
N/A

See Also

What is SciClone Pharmaceuticals (Holdings) Ltd's Revenue?
Revenue
3.2B CNY

Based on the financial report for Dec 31, 2023, SciClone Pharmaceuticals (Holdings) Ltd's Revenue amounts to 3.2B CNY.

What is SciClone Pharmaceuticals (Holdings) Ltd's Revenue growth rate?
Revenue CAGR 5Y
18%

Over the last year, the Revenue growth was 15%. The average annual Revenue growth rates for SciClone Pharmaceuticals (Holdings) Ltd have been 18% over the past three years , 18% over the past five years .